https://www.selleckchem.com/pr....oducts/pluronic-f-68
Patients were less likely to undergo IRT if they had private health insurance, were diagnosed with cancer stage IV, received no or laparoscopic cancer surgery or were treated in a hospital with medium vs. high surgical volume. The median follow-up time was 4.4 years (post-landmark). Utilization of IRT was associated with better overall (HR 0.81, 95% confidence interval 0.72-0.92) and disease-specific survival (HR 0.72, 95% confidence interval 0.61-0.85). Almost every other CRC patient underwent IRT. Next to clinical characteristic
Curtir
Comentario
Compartilhar
